CBAY — CymaBay Therapeutics Share News
0.000.00%
Last trade - 00:00- $3.73bn
- $3.44bn
- $31.07m
U.S. RESEARCH ROUNDUP-Bruker Corp, Cymabay Therapeutics, SSR Mining
U.S. RESEARCH ROUNDUP-An2 Therapeutics, Par Technology, Trimble
U.S. STOCKS ON THE MOVE-Perpetua Resources, Nvidia, SiriusXM
U.S. STOCKS ON THE MOVE-Lowe's, Bit Digital Snap
Deals of the day-Mergers and acquisitions
Brief: Cymabay Announces FDA Acceptance Of NDA And Priority Review For Seladelpar
CymaBay rises on $4.3 bln buyout deal by Gilead
Brief: Gilead Will Pay Cymabay Therapeutics Termination Fee Of $151.6 Mln If Agreement Is Terminated
Drugmaker Gilead to acquire CymaBay for $4.3 bln (updated)
Brief: Gilead Sciences Expands Liver Portfolio With Acquisition Of Cymabay Therapeutics
Gilead to acquire CymaBay for $4.3 bln
U.S. RESEARCH ROUNDUP-Array Technologies, Autodesk, Nike
U.S. STOCKS ON THE MOVE-Heritage Insurance, Steel Dynamics, Global Payments
CymaBay Therapeutics seeks US marketing approval for liver drug; shares up
Brief: CymaBay Submits New Drug Application To FDA For Seladelpar For The Treatment Of Primary Biliary Cholangitis
U.S. RESEARCH ROUNDUP- Pioneer Natural Resources,Oxford Industries, Nutrien
CymaBay Therapeutics Inc expected to post a loss of 30 cents a share - Earnings Preview
Brief: Cymabay Announces Publication Of Two-Year Safety And Efficacy Results
U.S. STOCKS ON THE MOVE-Hasbro, Moderna, CymaBay